Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for LMAT

Stock NameLeMaitre Vascular Inc
TickerLMAT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS5255582018
LEI549300FZUBUB7MHY8R17

Show aggregate LMAT holdings

News associated with LMAT

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Hold” from Analysts
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been assigned an average recommendation of “Hold” from the five analysts that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target […] - 2025-09-15 04:46:52
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) PT at $97.60
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been given an average recommendation of “Hold” by the five analysts that are covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target […] - 2025-09-15 04:46:48
Peek Under The Hood: SDVY Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-11 07:55:13
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $98.00 Consensus Price Target from Analysts
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six brokerages that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target […] - 2025-08-19 02:16:55
LeMaitre Vascular (NASDAQ:LMAT) Upgraded by Barrington Research to Outperform Rating
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) was upgraded by stock analysts at Barrington Research from a “market perform” rating to an “outperform” rating in a research report issued on Wednesday, MarketBeat.com reports. The brokerage presently has a $95.00 price objective on the medical instruments supplier’s stock. Barrington Research’s target price suggests a potential upside […] - 2025-08-08 02:40:48
LeMaitre Vascular Breaks Above 200-Day Moving Average - Bullish for LMAT
In trading on Wednesday, shares of LeMaitre Vascular Inc (Symbol: LMAT) crossed above their 200 day moving average of $89.93, changing hands as high as $96.14 per share. LeMaitre Vascular Inc shares are currently trading up about 11% on the day. The chart below shows the one y - 2025-08-06 12:48:00
LeMaitre (LMAT) Q2 Revenue Jumps 15%
Key PointsGAAP earnings per share were $0.60 for Q2 2025, beating analyst expectations of $0.57. - 2025-08-06 02:09:32
Lindenwold Advisors INC Sells 330 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Lindenwold Advisors INC lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 11.9% in the first quarter, Holdings Channel reports. The institutional investor owned 2,450 shares of the medical instruments supplier’s stock after selling 330 shares during the period. Lindenwold Advisors INC’s holdings in LeMaitre Vascular were worth $206,000 as […] - 2025-08-01 04:22:55
Alps Advisors Inc. Invests $354,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Alps Advisors Inc. purchased a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,220 shares of the medical instruments supplier’s stock, valued at approximately $354,000. Several other large investors have also modified […] - 2025-07-17 05:28:55
Envestnet Asset Management Inc. Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Envestnet Asset Management Inc. raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 9.9% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 285,109 shares of the medical instruments supplier’s stock after buying an additional 25,680 shares during the period. Envestnet Asset […] - 2025-07-16 04:50:54
New York State Teachers Retirement System Has $670,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
New York State Teachers Retirement System lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,989 shares of the medical instruments supplier’s stock after selling 200 shares during […] - 2025-07-11 05:15:00
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Teacher Retirement System of Texas
Teacher Retirement System of Texas lowered its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 73.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,534 shares of the medical instruments supplier’s stock after selling 75,317 shares during the period. […] - 2025-07-10 05:14:10
State of Alaska Department of Revenue Reduces Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
State of Alaska Department of Revenue lowered its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.3% in the 1st quarter, HoldingsChannel reports. The fund owned 11,337 shares of the medical instruments supplier’s stock after selling 262 shares during the period. State of Alaska Department of Revenue’s holdings in LeMaitre Vascular were worth […] - 2025-06-27 05:06:50
Farther Finance Advisors LLC Decreases Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Farther Finance Advisors LLC cut its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 20.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 783 shares of the medical instruments supplier’s stock after selling 202 shares during the quarter. Farther Finance […] - 2025-06-23 04:26:50
Fifth Third Bancorp Increases Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Fifth Third Bancorp grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The firm owned 10,903 shares of the medical instruments supplier’s stock after buying an additional 246 shares during the quarter. Fifth Third Bancorp’s holdings in LeMaitre Vascular were worth $915,000 at […] - 2025-06-17 04:51:01
Peek Under The Hood: SDVY Has 12% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-12 08:30:38
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Two Sigma Advisers LP
Two Sigma Advisers LP trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 28.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,300 shares of the medical instruments supplier’s stock after selling 7,200 shares during the period. Two Sigma Advisers LP’s holdings in LeMaitre Vascular were worth $1,686,000 at the […] - 2025-05-30 05:31:03
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. trimmed its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 62.7% in the fourth quarter, HoldingsChannel reports. The firm owned 18,571 shares of the medical instruments supplier’s stock after selling 31,233 shares during the period. D. E. Shaw & Co. Inc.’s holdings in LeMaitre Vascular […] - 2025-05-22 04:48:46
Captrust Financial Advisors Has $507,000 Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Captrust Financial Advisors decreased its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 11.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,500 shares of the medical instruments supplier’s stock after selling 706 shares during the period. Captrust Financial Advisors’ holdings […] - 2025-05-19 04:52:56
Ex-Dividend Reminder: Select Medical Holdings, LeMaitre Vascular and Selective Insurance Group
Looking at the universe of stocks we cover at Dividend Channel, on 5/15/25, Select Medical Holdings Corp (Symbol: SEM), LeMaitre Vascular Inc (Symbol: LMAT), and Selective Insurance Group Inc (Symbol: SIGI) will all trade ex-dividend for their respective upcoming dividends. Sele - 2025-05-13 12:47:45
Hsbc Holdings PLC Buys 1,170 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Hsbc Holdings PLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 43.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,861 shares of the medical instruments supplier’s stock after purchasing an additional 1,170 shares during the quarter. […] - 2025-05-09 05:38:59
LeMaitre Vascular (NASDAQ:LMAT) Trading 4.2% Higher After Dividend Announcement
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) shares shot up 4.2% during trading on Monday following a dividend announcement from the company. The company traded as high as $80.61 and last traded at $82.04. 19,169 shares were traded during trading, a decline of 88% from the average session volume of 162,392 shares. The stock […] - 2025-05-07 02:21:01
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $98.14
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have received an average rating of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy […] - 2025-04-30 02:34:48
Wells Fargo & Company MN Purchases 2,274 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Wells Fargo & Company MN boosted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 8.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 28,153 shares of the medical instruments supplier’s stock after acquiring an additional 2,274 shares during the quarter. Wells Fargo & Company MN’s holdings in LeMaitre […] - 2025-04-25 04:26:54
Alliancebernstein L.P. Purchases 1,287 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Alliancebernstein L.P. grew its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 6.0% during the 4th quarter, HoldingsChannel reports. The firm owned 22,584 shares of the medical instruments supplier’s stock after acquiring an additional 1,287 shares during the quarter. Alliancebernstein L.P.’s holdings in LeMaitre Vascular were worth $2,081,000 as of its most recent […] - 2025-04-17 04:30:59
Franklin Resources Inc. Grows Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Franklin Resources Inc. grew its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,678 shares of the medical instruments supplier’s stock after buying an additional 1,032 shares […] - 2025-04-15 04:56:59
Geode Capital Management LLC Purchases 7,737 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Geode Capital Management LLC lifted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 550,260 shares of the medical instruments supplier’s stock after buying an additional 7,737 shares during the […] - 2025-04-14 05:42:55
Envestnet Asset Management Inc. Increases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Envestnet Asset Management Inc. lifted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 7.0% during the fourth quarter, Holdings Channel reports. The firm owned 259,429 shares of the medical instruments supplier’s stock after acquiring an additional 16,886 shares during the period. Envestnet Asset Management Inc.’s holdings in LeMaitre Vascular were […] - 2025-04-14 04:48:50
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Trexquant Investment LP
Trexquant Investment LP cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 3.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 6,066 shares of the medical instruments supplier’s stock after selling 224 shares during the period. Trexquant Investment LP’s holdings in LeMaitre […] - 2025-04-13 07:09:04
Commonwealth Equity Services LLC Sells 2,171 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Commonwealth Equity Services LLC trimmed its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 21.8% during the fourth quarter, Holdings Channel reports. The firm owned 7,794 shares of the medical instruments supplier’s stock after selling 2,171 shares during the quarter. Commonwealth Equity Services LLC’s holdings in LeMaitre Vascular were worth $718,000 as of […] - 2025-04-03 04:20:47

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc LMAT holdings

DateNumber of LMAT Shares HeldBase Market Value of LMAT SharesLocal Market Value of LMAT SharesChange in LMAT Shares HeldChange in LMAT Base ValueCurrent Price per LMAT Share HeldPrevious Price per LMAT Share Held
2025-10-16 (Thursday)2,045USD 177,588USD 177,588
2025-10-15 (Wednesday)2,045USD 178,447USD 178,447
2025-10-13 (Monday)2,009USD 171,388USD 171,388
2025-10-09 (Thursday)2,009USD 175,426USD 175,426
2025-10-07 (Tuesday)2,009USD 174,361USD 174,361
2025-10-06 (Monday)2,003USD 175,242USD 175,242
2025-10-03 (Friday)2,003USD 175,964LMAT holding increased by 1963USD 175,9640USD 1,963 USD 87.8502 USD 86.8702
2025-10-02 (Thursday)2,003LMAT holding increased by 6USD 174,001LMAT holding increased by 921USD 174,0016USD 921 USD 86.8702 USD 86.67
2025-10-01 (Wednesday)1,997USD 173,080LMAT holding decreased by -1677USD 173,0800USD -1,677 USD 86.67 USD 87.5098
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LMAT by Blackrock for IE00B3VWM098

Show aggregate share trades of LMAT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-02BUY6 86.870* 89.27
2025-09-30BUY12 87.510* 89.29
2025-08-21SELL-6 96.450* 89.31 Profit of 536 on sale
2025-07-31BUY18 81.240* 89.32
2025-06-30SELL-12 83.050* 90.17 Profit of 1,082 on sale
2025-06-25SELL-6 84.540* 90.32 Profit of 542 on sale
2025-06-20SELL-12 81.780* 90.47 Profit of 1,086 on sale
2025-05-23BUY6 81.400* 91.85
2025-05-19SELL-6 85.960* 92.16 Profit of 553 on sale
2025-05-15SELL-18 83.300* 92.30 Profit of 1,661 on sale
2025-05-12SELL-6 82.460* 92.55 Profit of 555 on sale
2025-05-09SELL-6 80.260* 92.66 Profit of 556 on sale
2025-04-30SELL-6 90.740* 93.27 Profit of 560 on sale
2025-04-24SELL-12 91.760* 93.33 Profit of 1,120 on sale
2025-04-17SELL-6 86.280* 93.68 Profit of 562 on sale
2025-04-15SELL-18 84.630* 93.88 Profit of 1,690 on sale
2025-04-14SELL-18 83.780* 93.99 Profit of 1,692 on sale
2025-04-09SELL-24 83.900* 94.37 Profit of 2,265 on sale
2025-04-07SELL-42 79.390* 94.73 Profit of 3,979 on sale
2025-04-04SELL-60 79.780* 94.90 Profit of 5,694 on sale
2025-03-31BUY6 83.900* 95.25
2025-03-19SELL-12 84.820* 96.39 Profit of 1,157 on sale
2025-03-14SELL-36 81.910* 96.91 Profit of 3,489 on sale
2025-03-13SELL-12 78.820* 97.16 Profit of 1,166 on sale
2025-03-12SELL-204 81.520* 97.38 Profit of 19,867 on sale
2025-03-07SELL-12 81.370* 98.08 Profit of 1,177 on sale
2025-03-06SELL-18 82.490* 98.32 Profit of 1,770 on sale
2025-03-03SELL-6 92.160* 98.72 Profit of 592 on sale
2025-02-28SELL-36 91.850* 98.83 Profit of 3,558 on sale
2025-02-26SELL-6 103.050* 98.74 Profit of 592 on sale
2025-02-25SELL-18 104.000* 98.65 Profit of 1,776 on sale
2025-02-18BUY30 100.740* 98.32
2025-02-13BUY6 96.990* 98.33
2025-02-12BUY6 96.320* 98.37
2025-02-11BUY18 96.940* 98.40
2025-02-06BUY54 99.830* 98.38
2025-01-27BUY6 99.060* 98.36
2024-12-30BUY30 92.950* 98.84
2024-12-06BUY24 101.120* 98.80
2024-12-05BUY6 102.480* 98.67
2024-12-04BUY30 104.970* 98.45
2024-11-29BUY30 106.990* 97.56
2024-11-27BUY24 105.800* 96.85
2024-11-26BUY6 105.425* 96.46
2024-11-21BUY30 105.870* 94.80
2024-11-20BUY18 103.440* 94.32
2024-11-18BUY72 103.545* 93.15
2024-11-12BUY48 103.260* 92.48
2024-11-08BUY30 104.250* 91.64
2024-11-07BUY90 101.070* 90.91
2024-11-06BUY12 101.710* 90.01
2024-10-31BUY6 88.390* 87.73
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LMAT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1948,133086,11155.9%
2025-09-1833,733245,35174.4%
2025-09-1719,522028,33968.9%
2025-09-1672,014081,27888.6%
2025-09-15133,2190144,79792.0%
2025-09-1214,273022,99362.1%
2025-09-1125,498038,81165.7%
2025-09-1033,2991,16356,23159.2%
2025-09-0915,538027,40656.7%
2025-09-0825,08419535,74670.2%
2025-09-0539,294049,19579.9%
2025-09-0451,1533,07174,92568.3%
2025-09-0337,834044,72684.6%
2025-09-0234,6739049,09970.6%
2025-08-2916,2801927,95758.2%
2025-08-2824,937044,39856.2%
2025-08-2727,760043,71863.5%
2025-08-26201,5690237,35084.9%
2025-08-2537,78422187,84843.0%
2025-08-2229,055045,32364.1%
2025-08-21120,7960140,41486.0%
2025-08-2070,5920120,93758.4%
2025-08-1924,7401,00045,91153.9%
2025-08-1818,461037,19749.6%
2025-08-1572,2735,17890,27580.1%
2025-08-1444,275072,79860.8%
2025-08-1313,505025,34853.3%
2025-08-1238,979095,89940.6%
2025-08-1146,8729,55299,74147.0%
2025-08-0827,4332,47552,28552.5%
2025-08-0771,1115,83797,13773.2%
2025-08-0680,8040119,77467.5%
2025-08-0578,7500115,88768.0%
2025-08-0442,6862567,81862.9%
2025-08-0129,396045,22465.0%
2025-07-3125,326036,16870.0%
2025-07-3017,9032,02028,21163.5%
2025-07-2919,0862,06226,59171.8%
2025-07-2819,014029,84163.7%
2025-07-2530,1163439,74775.8%
2025-07-2420,148033,74659.7%
2025-07-2321,739035,10361.9%
2025-07-2223,3122,44733,01570.6%
2025-07-2119,745032,99159.8%
2025-07-1822,151035,52362.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.